DRUGS · SERVICE OVERVIEW

Drug FDA Compliance Service

Select the applicable FDA registration, listing, labelling, DMF technical documents and ongoing maintenance services along the two directions of pharmaceutical formulations and API, supplements and pharmamediatical packing.

EXPERIENCE IN PRACTICE

Medicines and DMF operations, with a genuine record of dealing with them.

See the work we have handled, from first-time filings to renewals and record maintenance.

306A drug and a DMF transaction log.

Based on historical company engagement records as of October 27, 2026. Counts include renewals, multiple services and possible duplicate records. They do not represent unique customers or FDA approvals.

View drugs and DMF cases *
START HERE

Let's sort out the product, then choose the service.

  1. 01

    Check the drug trail first.

    Provide composition, agent type, route of delivery, use and existing declared status.

  2. 02

    Clarifying the roles of business and products

    (c) To distinguish between manufacturing facilities, labelers and those responsible for associated information.

  3. 03

    Documentation and maintenance requirements

    Identify registration, listing, technical papers and information changes that need to be addressed.

SERVICE DIRECTORY

Selection of services by product orientation

Two types of clients have different products, uses and responsibilities, and please select the corresponding direction before looking at the specific work content.

01

Finished drugs

It is aimed at manufacturers of finished medicines, brands and labelers.

02

APIs, Excipients and Pharmaceutical Packaging

For manufacturers of pharmaceutical supply chain materials and holders of technical information.

These two directions are used to select services, not the official FDA classification. Specific registrations, listings, DDFs and other obligations need to be judged separately; Not all materials require the same formalities.

ONGOING SUPPORT

Drug projects need to be continuously checked against product life cycle

Discuss record maintenance →
  • To confirm whether relevant registration and listing information needs to be maintained when business activity, facility information, product state or party responsible changes.
  • Re-verification of existing declaration arrangements and applicable requirements in the event of changes in formulations, formulation types, labels or listing paths.
  • DMF documents, authorized references and technical updates should be linked to the application and the project scope identified by both parties.
BEFORE YOU DECIDE

You might care before you choose a pharmaceutical service.

Did you get the medication approved by completing the facility registration or by Drug Listing?

Doesn't mean that. Facilities registration, listing or NDC information is a different matter from listing approval for specific medicines.

Can OTC products be marketed on Monograph?

It cannot be judged by the name of the OTC alone. This is to be verified on a case-by-case basis in conjunction with product composition, agent type, adaptive condition, labelling and applicable conditions.

Can the DMF be listed as a separate product?

DMF is one of the mechanisms for the submission of technical information and is not equivalent to product approval; Its references and reviews need to be understood in the context of the linkage application path.

RELATED READING

Explore related rules and projects

Browse related guidance →
DEFINE YOUR NEXT STEP

Describe the product and the current phase and identify the next steps.

The composition, formulation type, intended use and the applicable listing path are checked first, and the specific service content and costs are subject to mutually confirmed project arrangements.